Latest Technology Platform News

Calix Limited reported a 17% rise in product and services revenue for FY25, driven by its Magnesia and Leilac businesses, alongside a 23% reduction in operating expenses. The company extended its cash runway to 18 months, supported by a $21 million equity raise, while progressing key decarbonisation projects.

Calix Limited reported solid FY25 results with 17% growth in product revenue, a 23% cut in operating costs, and an extended 18-month cash runway, while progressing key decarbonisation projects.

Calix Limited reported a $20.1 million loss for FY2025 despite an 11.2% increase in revenue, reflecting ongoing investment in its industrial decarbonisation technology platform.

Helloworld Travel Limited reported a 4.1% rise in profit after tax for FY25 despite an 8.6% decline in total transaction value, underpinned by strong forward bookings and ongoing technology investments.

Beforepay Group Limited reported a robust 74.5% increase in net profit after tax to $6.7 million for FY25, driven by growth in its core Pay Advance business, the launch of a Personal Loan product, and expansion of its AI-powered credit analytics division, Carrington Labs, in the US.

Noxopharm has successfully completed the third dosing phase of its HERACLES trial for SOF-SKN™, confirming safety and moving forward to the highest dose cohort in this pioneering autoimmune drug study.

Vitura Health reported modest revenue growth but a robust 23.5% increase in EBITDA for FY2025, fueled by key acquisitions and expanding telehealth services. Despite margin pressures in medicinal cannabis, the company’s strategic reset under new leadership sets the stage for further growth.

Vitura Health reported a modest revenue increase to $124 million for FY2025, while net profit dipped 5.35% due to margin pressures and investment in new platforms. The company declared a fully franked dividend and highlighted growth in telehealth and medical services.

PeopleIN’s FY2025 results reveal a revenue dip amid challenging conditions, offset by strategic cost savings, strong cash flow, and a $6 million share buy-back, positioning the company for growth in Queensland and Defence sectors.

INOVIQ Limited reported a $6.9 million net loss for FY25 while making significant strides in its exosome-based cancer diagnostics and therapeutics pipeline, including a breakthrough ovarian cancer screening test and promising CAR-exosome therapy results.

Credit Clear Limited has reported a remarkable turnaround in FY25, posting record revenue growth and a return to profitability driven by its innovative AI-powered debt resolution platform.

Cogstate Ltd has reported a strong FY25 with 22% revenue growth and a near doubling of profit before tax, declaring its first fully franked dividend and preparing to launch its inaugural AI-powered product in FY26.